Results 61 to 70 of about 26,766 (270)

Understanding delays in breast cancer diagnosis in Africa: Key insights and contributing factors

International Journal of Cancer, EarlyView.
What's New? Despite lower incidence rates, Africa has the highest age‐standardized breast cancer mortality rates globally. Using Bronfenbrenner's ecological model to classify multilevel influences on the individual, this scoping review shows that a lack of knowledge about breast cancer is the primary factor contributing to breast cancer diagnostic ...
Liza A. Hoveling, Lynn P. Heuken, Thachita Harfst, Melinda S. Schuurman, Kristel M. van Asselt, Sabine Siesling, Christina Bode   +6 more
wiley   +1 more source

Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994 [PDF]

, 2017
Background: To analyse trends in incidence, survival and risk of second neoplasms following vaginal and vulvar cancers using data collected by the Swiss Cancer Registry of Vaud over the 21-year period 1974-1994.
La Vecchia, C., Levi, F., Randimbison, L.   +2 more
core  

A case of HPV-53-related cervical cancer in an elderly patient [PDF]

, 2014
Zappacosta et al1 recently published a case report concerning a human papillomavirus (HPV)-positive invasive cervical cancer in a 79-year-old women who had a history of normal Pap smears.
Lieveld, Marusya, Padalko, Elizaveta, Praet, Marleen, Vanden Broeck, Davy   +3 more
core   +3 more sources

Environment, lifestyle, and cancer in women

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Environmental and lifestyle factors significantly contribute to gynecological cancers. The risk of ovarian cancer, one the most lethal gynecological cancer, is associated with obesity, poor dietary habits, and environmental pollutants, exacerbating hormonal imbalances, inflammation, and oxidative stress.
Sara Farina, Alessandra Sabatelli, Stefania Boccia, Giovanni Scambia   +3 more
wiley   +1 more source

Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study

Journal of the Egyptian National Cancer Institute, 2017
Objective: To describe for the first time the epidemiologic and clinico-pathologic characteristics of vulvar cancer in Tunisia. Design: Two parts are distinguished in this study: Part1: Multicentric retrospective study about the characteristics of all ...
Mehdi Kehila, MD, Souad Harabi, MD, Raoudha Mhiri, MD, Omar Touhami, MD, Hassine Saber Abouda, MD, Abdeljalil Khlifi, MD, Mohamed Hsairi, PhD, Dalenda Chelli, PhD, Mohamed Derbel, MD, Sahbi Kebaili, MD, Nadia Boujelbane, MD, Kais Chaabene, PhD, Mohamed Badis Chanoufi, PhD   +12 more
doaj   +1 more source

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer [PDF]

, 2012
A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly.
A Lundqvist, A Somers, C Berger, CA Tran, Carolina Berger, Cornelis JM Melief, Daniel J Powell, David F Stroncek, DG Song, DJ Powell Jr, DL Porter, Francesco M Marincola, G Mostoslavsky, GG Kenter, Gustavo Mostoslavsky, J Jin, J Staerk, James R Heath, Jeffrey S Miller, JN Kochenderfer, JN Kochenderfer, John O'Shea, JS Miller, K Takahashi, L Gattinoni, L Gattinoni, L Gattinoni, L Gattinoni, LA Johnson, Luca Gattinoni, M Kalos, M Kalos, M Kalos, Mahendra Rao, Mark E Dudley, Martin A Cheever, ME Dudley, ME Dudley, Michael Kalos, Nicholas P Restifo, P Muranski, Peter Flynn, PF Robbins, RA Morgan, Richard W Childs, SA Rosenberg, Steven A Rosenberg, TS Park, X Wang   +48 more
core   +4 more sources

Cancer in pregnancy: FIGO Best practice advice and narrative review

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda, Melanie Nana, Long Nguyen‐Hoang, Sumaiya Adam, Fionnuala McAuliffe, Lina Bergman, Sarikapan Wilailak, Orla McNally, Cynthia V. Maxwell, Nikhil Purandare, Bo Jacobsson, Virna P. Medina, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Ernesto Castelazo, Graeme N. Smith, Sharleen L. O'Reilly, Patrick O'Brien, Mark Hanson, Mary L. Rosser, Claudio Sosa, Valerie Guinto, Jonathan Berek, Catherine Nelson‐Piercy, Frédéric Amant, Liona Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health, FIGO Committee on Women's Cancer, and the FIGO Division of Maternal and Newborn Health   +29 more
wiley   +1 more source

Cancer of the vagina: 2025 update

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Primary vaginal cancer is a rare gynecologic malignancy, with most vaginal cancers representing metastases from other primary sites. Staging and treatment protocols are often extrapolated from those used in cervical cancer. In contemporary medicine, the roles of the pathologist and radiologist are increasingly vital in supporting diagnosis and
Tracey S. Adams, Jackie Choekoe Maluleke, Mauricio A. Cuello   +2 more
wiley   +1 more source

Current Techniques for Detecting Sentinel Lymph Nodes in Vulvar Cancer

Креативная хирургия и онкология, 2019
Introduction. Vulvar cancer belongs to the group of rare neoplasms and accounts for about 4% of all gynecological malignant tumours. One of the important barriers to the spread of the tumour cell population is the lymph nodes.
Sh. Kh. Gantsev, O. N. Lipatov, K. V. Menshikov   +2 more
doaj   +1 more source

Interstitial brachytherapy with 192Ir in vulvar cancer [PDF]

, 2006
Vulvar cancer accounts for 5% of all female genital cancers and 1% of all malignancies in women. A female patient, 78 years old, with diagnosed squamous cell carcinoma of vulva stage II, was admitted to our Institution in January 2004. An exophytic tumor,
Baucal Milutin, Bugarčić Biljana, Erak Dragica, Erak Marko, Mandić Aljoša, Novaković Petar   +5 more
core   +1 more source